LG G PAD 7.0 LTE User Manual page 142

Safety
142
(by heating tissue), exposure to low level RF that does not produce heating
effects causes no known adverse health effects. Many studies of low level
RF exposures have not found any biological effects. Some studies have
suggested that some biological effects may occur, but such findings have
not been confirmed by additional research. In some cases, other
researchers have had difficulty in reproducing those studies, or in
determining the reasons for inconsistent results.
2. What is the FDA's role concerning the safety of wireless tablets?
Under the law, the FDA does not review the safety of radiation-emitting
consumer products such as wireless tablets before they can be sold, as it
does with new drugs or medical devices. However, the agency has
authority to take action if wireless tablets are shown to emit Radio
Frequency (RF) energy at a level that is hazardous to the user. In such a
case, the FDA could require the manufacturers of wireless tablets to notify
users of the health hazard and to repair, replace, or recall the tablets so that
the hazard no longer exists.
Although the existing scientific data does not justify FDA regulatory actions,
the FDA has urged the wireless tablet industry to take a number of steps,
including the following:
• Support needed research into possible biological effects of RF of the type
emitted by wireless tablets;
• Design wireless tablets in a way that minimizes any RF exposure to the
user that is not necessary for device function; and
• Cooperate in providing users of wireless tablets with the best possible
information on possible effects of wireless tablet use on human health.
The FDA belongs to an interagency working group of the federal agencies
that have responsibility for different aspects of RF safety to ensure
coordinated efforts at the federal level. The following agencies belong to
this working group:
• National Institute for Occupational Safety and Health
• Environmental Protection Agency